Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page changed from showing 'No Results Posted' to 'Results Submitted', indicating that results have been submitted for posting.
    Difference
    0.1%
    Check dated 2025-12-09T18:55:25.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Publications section now notes items are auto-filled from PubMed and may not pertain to the study. The revision history updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:48:56.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The government funding status notice about potential data delays was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:16:32.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The new screenshot shows a redesigned layout of the study details page with the same sections and content as before. No substantive data changes observed (enrollment, status, eligibility criteria, or outcomes appear unchanged). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:24:46.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page now includes a government funding lapse notice and an updated version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:52:07.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. No other content changes observed.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:02.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.